STAT5B and pachyonychia congenita: Pharmacological inhibition of Stat5 activity in PC cancer by a specific small-molecule Stat5 inhibitor, IST5-002 (36, 39, 40, 47), suppressed Stat5-regulated genes, and AR and AR-regulated genes resulting in reduced PC cell viability and tumor growth.